Regulation of 5-phosphoribosyl 1-pyrophosphate and of hypoxanthine uptake and release in human erythrocytes by oxypurine cycling.
Uptake and release of purines by red blood cells has been shown to be markedly sensitive to changes in pH, inorganic phosphate (Pi), and oxygen concentration (Berman, P., Black, D., Human, L., and Harley, E. (1988) J. Clin. Invest. 82, 980-986). The mechanism of this regulation has been further studied. We have shown that incubation of red cells in medium containing xanthine oxidase rapidly and completely depletes intracellular hypoxanthine and causes accumulation of 5-phosphoribosyl 1-pyrophosphate (PRPP) at physiological Pi concentrations. Hypoxanthine release from intracellular IMP is strictly dependent on PRPP depletion, induced by either alkalinizing the cells or by adding excess adenine. Xanthine oxidase abolishes this dependence. Oxygen depletion enhances adenine uptake and prevents hypoxanthine release. The results suggest that hypoxanthine release is governed by PRPP-dependent recycling of hypoxanthine to IMP. We propose that PRPP accumulation in red cells is regulated by a substrate cycle, comprising hypoxanthine, IMP, and inosine. Cycle flux is controlled by Pi inhibition and 2,3-bisphosphoglycerate activation of purine-5'-nucleotidase, which converts IMP to inosine. Oxypurine cycling may account for the sensitive control of purine uptake and release by changes in pH and oxygen tension that occur physiologically.
Berman
P A
PA
Department of Chemical Pathology, University of Cape Town Medical School, Observatory, South Africa.
Human
L
L
D001692:Biological Transport / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000097:blood*; D066298:In Vitro Techniques; D007700:Kinetics; D008954:Models, Biological; D009708:Nucleotidases / Q000097:blood; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010428:Pentosephosphates / Q000097:blood*; D010754:Phosphoribosyl Pyrophosphate / Q000097:blood*; D011685:Purine Nucleotides / Q000097:blood / Q000302:isolation & purification; D011687:Purines / Q000097:blood / Q000302:isolation & purification; D014969:Xanthine Oxidase / Q000097:blood
D007042:Hypoxanthines; D010428:Pentosephosphates; D011685:Purine Nucleotides; D011687:Purines; D019271:Hypoxanthine; D010754:Phosphoribosyl Pyrophosphate; D014969:Xanthine Oxidase; D009708:Nucleotidases; C029296:purine 5'-nucleotidase; D010100:Oxygen